COVID-19 Vaccination in Pregnancy Safe for Infant Neurodevelopment
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 23, 2024 -- COVID-19 vaccination during pregnancy seems safe in terms of neurodevelopment through 18 months of age, according to a study published online Jan. 22 in JAMA Pediatrics.
Eleni G. Jaswa, M.D., from the University of California in San Francisco, and colleagues conducted a prospective cohort study, Assessing the Safety of Pregnancy During the Coronavirus Pandemic (ASPIRE), to examine whether in utero exposure to maternal COVID-19 vaccination is associated with differences in scores on the Ages and Stages Questionnaire, third edition (ASQ-3), at ages 12 and 18 months. A total of 2,487 pregnant participants were enrolled at less than 10 weeks of gestation. Neurodevelopmental assessments were included for 2,261 and 1,940 infants aged 12 and 18 months, respectively.
The researchers found that 30.6 percent of 1,541 exposed infants and 28.2 percent of 720 unexposed infants screened abnormally for developmental delay at 12 months; the corresponding prevalences were 20.1 and 23.2 percent of 1,301 and 639 infants at 18 months, respectively. After adjustment for confounding variables, including maternal age, race, ethnicity, education, income, maternal depression, and anxiety, there was no difference seen in risk for abnormal ASQ-3 screened at 12 or 18 months. The results were not affected after further adjustment for preterm birth and infant sex.
"These data suggest that maternal vaccination against COVID-19 during pregnancy was safe from the perspective of offspring neurodevelopment through 18 months of age," the authors write.
The ASPIRE Study was partially funded by pharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Further Support and Information on COVID-19
Read this next
At-School Vaccination Boosts HPV Vaccination Coverage
THURSDAY, May 30, 2024 -- At-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination coverage among adolescents, according to a study published...
American College of Obstetricians and Gynecologists, May 17-19
The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...
Epidural Analgesia Linked to Decline in Severe Maternal Morbidity
FRIDAY, May 24, 2024 -- Epidural analgesia during labor is associated with a reduction in severe maternal morbidity (SMM), according to a study published online May 22 in The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.